The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

PharMerica Corp

NYSE: PMC
Last

(U.S.) $26.05

Today's change0.00 0.00%
Updated January 17 4:02 PM EST. Delayed by at least 15 minutes.
 

PharMerica Corp

NYSE: PMC
Last

(U.S.) $26.05

Today's change0.00 0.00%
Updated January 17 4:02 PM EST. Delayed by at least 15 minutes.

PharMerica Corp closed at (U.S.)$26.05.

Over the last five days, shares have gained 0.97%, but are down 17.25% for the last 52 weeks, lagging the 20.61% return in the S&P 500.

Key company metrics

  • Open(U.S.) $25.90
  • Previous close(U.S.) $26.05
  • High(U.S.) $26.65
  • Low(U.S.) $25.75
  • Bid / Ask-- / --
  • YTD % change+3.58%
  • Volume142,583
  • Average volume (10-day)144,604
  • Average volume (1-month)194,012
  • Average volume (3-month)275,207
  • 52-week range(U.S.) $19.20 to (U.S.) $32.18
  • Beta1.11
  • Trailing P/E23.52×
  • P/E 1 year forward13.96×
  • Forward PEG2.88×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.11
Updated January 17 4:02 PM EST. Delayed by at least 15 minutes.
S&P TSX0.25%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue513520525521
Total other revenue--------
Total revenue513520525521
Gross profit79828287
Total cost of revenue434438443434
Total operating expense501512517501
Selling / general / administrative53565755
Research & development--------
Depreciation / amortization8888
Interest expense (income), net operating--------
Unusual expense (income)51093
Other operating expenses, total--------
Operating income128820
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax94519
Income after tax73420
Income tax, total221-1
Net income73420
Total adjustments to net income--------
Net income before extra. items73420
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items73420
Inc. avail. to common incl. extra. items73420
Diluted net income73420
Dilution adjustment--------
Diluted weighted average shares31313131
Diluted EPS excluding extraordinary itemsvalue per share0.230.080.130.66
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.370.280.380.73